Point-of-care antigen test for rapid detection of SARS-CoV-2 in patient samples. Provides results within minutes for COVID-19 screening and diagnosis in clinical and community settings.
Manufactured by
Shanghai, China
The two Production Plants of Shanghai Chemtron Biotech Co., Ltd. are located in the International Medical Park, Zhangjiang Development Zone, Pudong New District and Xiasha Town, Pudong New District in Shanghai. Chemtron was founded in January 2001, a high-tech enterprise in Shanghai, a vice president unit of the medical laboratory industry branch of the health industry management association, and a patent demonstration enterprise in Shanghai. Chemtron specializes in R D, production, sales and services of in-vitro rapid detection of diagnostic reagents. Chemtron has Production Plants over 17000 square meters with facilities for advanced R D, production, quality inspection equipment and instruments of in-vitro diagnostic reagent with an annual production capacity of 320 million. In San Diego, California, the United States, Chemtron (U.S.) company has established a sole-owned product development center and production plant. At present, there are 194 employees, 110 with Bachelor s degree or above including 3 Doctors, 10 Masters, accounting for 52.9% of the total employees of the company. In 2004, Chemtron passed the international certification of ISO13485 authoritative quality system; in March 2005, Chemtron passed the GMP certification of the State Food and drug administration; in 2009, it was listed in the biomedical industrialization project of Shanghai government; Chemtron s main products obtained the CE certificate in EU; 12 drug testing products series have obtained the FDA certification of the United States. Chemtron has established a first-class “Chemtron R D technology center” in the United States and China. Based on the platform of monoclonal antibody technology and laboratory medicine technology, Chemtron has speeded up the R D and marketing of its products. Chemtron has continuously developed and launched fast, sensitive, specific and accurate in-vitro diagnostic products. Chemtron now has a series of in-vitro diagnostic reagents under the national registered trademark Chemtrue , with a total of 6 series of products of more than 40 varieties: such as drug detection; tumor detection; infectious disease detection; cardiovascular disease detection; hormone detection and POCT rapid quantitative intelligent instrument with supporting CRP, HCG, MAU, cTnI, myocardial infarction three-in-one, PCT, D2 polymer and other products. Chemtron has always adhered to the business philosophy of quality, reputation, service and sincerity and the quality policy of perfect quality, standardized management, innovation and sincere service . Chemtron s products are sold to over 70 countries and regions around the world, such as the United States, Russia, Europe, South America, Middle East, East Asia, etc. Chemtron is willing to work together with you to relieve human suffering!
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Guangzhou Shengwei Medical Devices Co., Ltd.
China · 2 relevant products
JULI MEDICAL LIMITED
China · 3 relevant products
HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO., LTD
China · 1 relevant product
Ningbo Masschip Intelligent Technology Co., Ltd.
China · 1 relevant product
SHENZHEN LVSHIYUAN BIOTECHNOLOGY CO.,LTD
China · 1 relevant product
SHENZHEN MAIDE BIOTECHNOLOGY CO.,LTD
China · 1 relevant product
YASEE BioMedical Inc.
China · 1 relevant product
Anbio Biotechnology Limited
Germany · 1 relevant product
Hangzhou Frenovo Biotech Co., Ltd
China · 2 relevant products
AEHEALTH Limited
China · 1 relevant product
87 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 116 closest product alternatives
Guangzhou Shengwei Medical Devices Co., Ltd. · China
Point-of-care antigen test for rapid COVID-19 detection. Enables quick identification of active viral infection in clinical and non-clinical settings.
JULI MEDICAL LIMITED · China
Rapid antigen detection test for acute SARS-CoV-2 infection. Provides results within minutes for immediate clinical decision-making.
HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO., LTD · China
Rapid test kit for detecting SARS-CoV-2 antigens. Provides point-of-care diagnosis for COVID-19 infection.
Ningbo Masschip Intelligent Technology Co., Ltd. · China
Rapid antigen detection test for SARS-CoV-2 identification. Suitable for screening and confirmatory testing in clinical and community settings.
SHENZHEN LVSHIYUAN BIOTECHNOLOGY CO.,LTD · China
Point-of-care (POCT) antigen detection test for SARS-CoV-2. Provides rapid qualitative results for COVID-19 diagnosis. Included on manufacturer whitelist for approved diagnostic suppliers.
SHENZHEN MAIDE BIOTECHNOLOGY CO.,LTD · China
Point-of-care rapid antigen test for SARS-CoV-2 detection with results available within 15-20 minutes. Designed for clinical use in hospitals, clinics, and testing centers with high sensitivity and specificity.
YASEE BioMedical Inc. · China
Point-of-care rapid test for detection of SARS-CoV-2 viral antigens. Supports clinical diagnosis and mass screening during pandemic response.
Anbio Biotechnology Limited · Germany
Point-of-care immunoassay for rapid detection of COVID-19 antigens in clinical samples. Delivers results within 15-30 minutes for immediate clinical decision-making.
Hangzhou Frenovo Biotech Co., Ltd · China
Rapid diagnostic test for detection of SARS-CoV-2 antigen. Provides quick identification of active COVID-19 infection for point-of-care testing.
AEHEALTH Limited · China
Rapid immunoassay-based test for SARS-CoV-2 antigen detection. Enables quick screening and diagnostic confirmation for COVID-19.
SKYPRO Medical Supplies · Hong Kong
A rapid antigen test for detecting COVID-19 infection.
Anhui Deepblue Medical Technology Co., Ltd. · China
Rapid antigen detection immunoassay for SARS-CoV-2 diagnosis. Delivers results in minutes from nasopharyngeal or oropharyngeal samples for point-of-care testing.
104 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products